Tuis1177 • HKG
add
Sino Biopharmaceutical Ltd
Vorige sluiting
$2,85
Dagwisseling
$2,83 - $2,90
Jaarwisseling
$2,29 - $4,25
Markkapitalisasie
54,15 mjd HKD
Gemiddelde volume
51,65 m
P/V-verhouding
12,23
Dividend-opbrengs
2,08%
Primêre beurs
HKG
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 7,94 mjd | 11,14% |
Bedryfskoste | 4,78 mjd | 10,58% |
Netto inkomste | 1,51 mjd | 139,69% |
Netto winsgrens | 19,01 | 115,78% |
Wins per aandeel | — | — |
EBITDA | 1,98 mjd | 8,88% |
Effektiewe belastingkoers | 16,99% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 13,18 mjd | -15,93% |
Totale bates | 66,70 mjd | 1,62% |
Totale aanspreeklikheid | 24,58 mjd | -15,76% |
Totale ekwiteit | 42,12 mjd | — |
Uitstaande aandele | 18,21 mjd | — |
Prys om te bespreek | 1,58 | — |
Opbrengs op bates | 6,50% | — |
Opbrengs op kapitaal | 8,37% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,51 mjd | 139,69% |
Kontant van bedrywe | 1,54 mjd | 15,25% |
Kontant van beleggings | -1,02 mjd | 49,91% |
Kontant van finansiering | -2,05 mjd | -1,42% |
Netto kontantverandering | -1,52 mjd | 43,37% |
Beskikbare kontantvloei | 1,09 mjd | 36,59% |
Meer oor
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
HUB
Gestig
2000
Webwerf
Werknemers
24 437
